Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Am J Kidney Dis. 2015 Apr 29;66(3):429–440. doi: 10.1053/j.ajkd.2015.02.324

Table 5.

Multivariable Adjusted Competing Risks of Cause-Specific Mortality According to Baseline eGFR

Type of Death Q1: 0.9-24.2 (n = 1,008) Q2: 24.3-31.6 (n = 1,014) Q3: 31.7-40.2 (n = 1,007) P
Overall 1.83 (1.50-2.23) 1.23 (0.99-1.51) 1.08 (0.87-1.34) <0.001
CV death 1.53 (1.17-1.99) 1.16 (0.88-1.54) 1.11 (0.84-1.48) 0.002
    Fatal MI 1.55 (0.79-3.05) 1.15 (0.55-2.42) 0.60 (0.25-1.43) 0.09
    Fatal stroke 2.71 (0.97-7.57) 2.60 (0.92-7.35) 1.96 (0.66-5.80) 0.04
    Presumed CV death 1.42 (0.67-3.04) 1.29 (0.61-2.74) 1.16 (0.52-2.59) 0.3
    Pump failure 1.17 (0.62-2.22) 1.04 (0.54-2.01) 0.81 (0.41-1.62) 0.5
    CV other 0.52 (0.15-1.78) 1.40 (0.51-3.82) 0.73 (0.23-2.30) 0.6
    Presumed sudden death 1.99 (0.75-5.27) 0.96 (0.32-2.91) 1.86 (0.70-4.95) 0.4
    Definite sudden death 1.62 (1.03-2.54) 0.91 (0.54-1.53) 1.28 (0.79-2.07) 0.1
    Definite or presumed sudden death 1.69 (1.12-2.54) 0.92 (0.58-1.47) 1.38 (0.90-2.12) 0.06
Non-CV death 2.11 (1.52-2.93) 1.31 (0.92-1.86) 1.04 (0.71-1.51) <0.001
    Infection 2.74 (1.50-5.02) 1.74 (0.90-3.34) 1.16 (0.56-2.37) <0.001
    Malignancy 1.16 (0.56-2.37) 1.30 (0.66-2.55) 0.73 (0.34-1.57) 0.4
    Other 1.81 (1.06-3.09) 0.93 (0.50-1.71) 0.97 (0.54-1.77) 0.04
    Renal 4.57 (1.33-15.74) 2.00 (0.52-7.64) 2.35 (0.62-8.85) 0.01
Unknown 1.52 (0.77-3.00) 1.18 (0.58-2.41) 0.99 (0.47-2.10) 0.2

Note: Values are given as hazard ratio (95% confidence interval). eGFR quartiles expressed in mL/min/1.73 m2; Q4 (40.3-119.8 mL/min/1.73 m2) is reference group (n = 1,006). Multivariable competing-risks models for specific causes of death. All models adjusted for for treatment, age, race, sex, diabetes, duration of diabetes, systolic and diastolic blood pressure, and history of CV disease.

Abbreviations: CV, cardiovascular; eGFR, estimated glomerular filtration rate; MI, myocardial infarction; Q, quartile.